United Therapeutics Corporation

(NASDAQ:UTHR)

65.47

-0.05 (-0.08%)

Jan 08 - Close

Open
66.03
High
66.03
Low
63.73
Vol.
388.00K
Mkt Cap
1.52B
52Wk High
117.82
52Wk Low
47.63
Avg. Vol.
323.50K
P/E (Trailing)
39.92
Beta
0.00
Short %
12.60%
Div. Yield
—

After-Hours 65.47 0.00 (0.00%) Thu, 8 Jan 2009 7:40 PM

Company Profile

United Therapeutics Corporation

1110 Spring Street

Silver Spring, MD 20910

United States - Map

Phone: (301) 608-9292

Fax: (301) 608-9291

Website: www.unither.com

State of incorporation: Delaware

CEO: Dr. Martine A. Rothblatt, Ph.D., J.D.

Employees: 320

Sector: Healthcare

Industry Group: Drugs

Industry: Drug Manufacturers - Other

Develops pharmaceuticals to treat vascular disease

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Recent news for UTHR

Members owning UTHR also own

PFE (66.67%), AMED (33.33%), ENDP (33.33%), MICC (33.33%), VSEA (33.33%)

Member sentiment (?)    Neutral

- MarketGuru Blog network-

Top members owning UTHR

* Average monthly return vs. S&P 500

Recent opinions on UTHR

No recent Opinions for UTHR